AI assistant
Sending…
Vericel Corp — Director's Dealing 2014
Jan 8, 2014
31799_dirs_2014-01-08_944e1970-11f6-413c-8af1-c85990228bcc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AASTROM BIOSCIENCES INC (ASTM)
CIK: 0000887359
Period of Report: 2014-01-03
Reporting Person: Orlando Daniel (Chief Operating Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-01-03 | Stock Option (right to buy) | $3.57 | A | 33000 | Acquired | 2024-01-03 | Common Stock (33000) | Direct |
Footnotes
F1: These options vest quarterly over four years commencing on the date of grant.
More from Vericel Corp
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 1
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 19
Proxy Solicitation & Information Statement
2026
Mar 19
Annual Report
2026
Mar 19